Template to add a clinical trial

WikiDoc Resources for Template to add a clinical trial
Articles
Most recent articles on Template to add a clinical trial Most cited articles on Template to add a clinical trial Review articles on Template to add a clinical trial Articles on Template to add a clinical trial in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Template to add a clinical trial Images of Template to add a clinical trial Photos of Template to add a clinical trial Podcasts & MP3s on Template to add a clinical trial Videos on Template to add a clinical trial
Evidence Based Medicine
Cochrane Collaboration on Template to add a clinical trial Bandolier on Template to add a clinical trial TRIP on Template to add a clinical trial
Clinical Trials
Ongoing Trials on Template to add a clinical trial at Clinical Trials.gov Trial results on Template to add a clinical trial Clinical Trials on Template to add a clinical trial at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Template to add a clinical trial NICE Guidance on Template to add a clinical trial NHS PRODIGY Guidance FDA on Template to add a clinical trial CDC on Template to add a clinical trial
Books
Books on Template to add a clinical trial
News
Template to add a clinical trial in the news Be alerted to news on Template to add a clinical trial News trends on Template to add a clinical trial
Commentary
Blogs on Template to add a clinical trial
Definitions
Definitions of Template to add a clinical trial
Patient Resources / Community
Patient resources on Template to add a clinical trial Discussion groups on Template to add a clinical trial Patient Handouts on Template to add a clinical trial Directions to Hospitals Treating Template to add a clinical trial Risk calculators and risk factors for Template to add a clinical trial
Healthcare Provider Resources
Symptoms of Template to add a clinical trial Causes & Risk Factors for Template to add a clinical trial Diagnostic studies for Template to add a clinical trial Treatment of Template to add a clinical trial
Continuing Medical Education (CME)
CME Programs on Template to add a clinical trial
International
Template to add a clinical trial en Espanol Template to add a clinical trial en Francais
Business
Template to add a clinical trial in the Marketplace Patents on Template to add a clinical trial
Experimental / Informatics
List of terms related to Template to add a clinical trial

How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections. More help to add a trial here.

European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

Study Acronym (The trial's abbreviation if there is one)

Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K; EUROTRANSFER Registry Investigators.

BACKGROUND: Abciximab is established as adjunct to primary percutaneous coronary intervention (PCI). Based on some smaller studies, ST-segment elevation myocardial infarction (STEMI) networks in various European countries have adopted the start of abciximab before transfer to the catheterization laboratory (cathlab) hospital as part of their routine treatment options. Although a recently published study did not reveal improved clinical outcome when starting abciximab before the cathlab, a potential benefit from such early administration, in particular in the setting of transfer networks, remains unclear and has been the subject of debate.

Patients with ST-Elevation MI

Natural History, Cross-Sectional, Defined Population, Prospective Study

Study Arms and How They Were Treated (Intervention) (Explanation here)

None reported

Primary Pre-Specified Endpoint

None reported

Secondary Endpoints

None reported

Inclusion Criteria

PATIENTS:

All consecutive STEMI patients >=18years arriving to the Cath Lab hospital (invasive facility center) from transfer.

Transfer with respect to this registry is defined as patients that reach the Cath Lab hospital:

transferred from a surrounding regional community hospitals that the Cath Lab hospital has an established referral pattern with or after being picked–up by an ambulance which is equipped/staffed to provide specific medical therapy (like prehospital thrombolysis or upstream abciximab). Usually these have a physician or specifically trained nurse on board.

Exclusion Criteria

Exclusion Criteria:

Patients who arrive to the Cath Lab from other pathways than those specified above (a. and b.), e.g. those who come by ambulances that do not provide specific medical therapy or arrive directly to the ER of the Cath Lab hospital by own feet/car will not be included in this registry. Patients from controlled clinical trials shall be included as long as their actual treatment is fully known. Thus, participants from randomized trials with blinded treatment cannot be included in this registry.

Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available)

None reported

Conclusions of the Investigators (Quote the investigators conclusions here)

None reported

Commentary, Discussion and Limitations of the Trial (Anyone can add comments)

None reported

Slides

None reported

Video Commentary

None reported

References (How to insert a reference)

None reported

External sites for further information (How to insert links)

None reported

Ages

__ years to ___ years

Gender (Indicate whether men, women or both were enrolled)

None reported

Accepts Healthy Volunteers (Answer yes or no)

None reported

Enrollment Period (Study start and end date)

None reported

Recruitment Status (explanation)

None reported

Enrollment (Total number of patients enrolled)

None reported

Study Sponsor (e.g. Investigator initiated or company name)

None reported (this may not have yet been ascertained)

Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)

None reported

The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.